| Factor Information | |
|---|---|
| Data ID | 88 |
| Factor | fontan status (Predictors of Recurrence After First Catheter Ablation) |
| Description | Univariate predictors of AT recurrence included Fontan status, prior surgical maze procedure, and pre-procedural failure of amiodarone therapy |
| Biomarker | YES |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | diagnosis |
| Objective | To access a negative predictor of AT-free survival |
| p Value | 0.02 |
| HR | 2.14 |
| Conclusion | Univariate predictors of AT recurrence included Fontan status, prior surgical maze procedure, and pre-procedural failure of amiodarone therapy |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 413 |
| CHD Type | isolated CHD |
| CHD Subtype | ASD, VSD/AS, BAV/TOF, PS/AVC/ECD/EA/other |
| Reference | |
|---|---|
| PMID | 31000097 |
| Year | 2019 |
| Title | Catheter Ablation for Atrial Tachycardia in Adults With Congenital Heart Disease: Electrophysiological Predictors of Acute Procedural Success and Post-Procedure Atrial Tachycardia Recurrence |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | chart and procedure report | |
| Region | Columbia, United States | |
| Method | a retrospective study | |
| Race | North America | |
| Disease History | ATs [Of the AT, 179 (93%) were intra-atrial macro-re-entrant tachycardia, and 12 (7%) had a focal origin.] | |
| Treatment History | Underwent catheter ablation for 182 AT; medians includes amiodarone(22), sodium channel blockers(1), beta-bolckers(78), sotalol(14), calcium-channel blockers(8). | |
| Group | fontan status(Treatment) | without fontan status(Control) |
| Number | 20(total:140) | 120(total:140) |
| Age | 45±1.2 (mean ± SEM) | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | N/A | N/A |
